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Abstract
Objectives The scope of this cross-sectional observational study is to evaluate prevalence of reporting the 19
objective items of the REFLECT statement checklist (Sargeant et al., 2010), with the primary outcome being
prevalence of sample size calculation, in clinical trials published in the Journal of Dairy Science from January
to December of 2017. We will also determine risk of bias in individual studies using the Cochrane Risk of Bias
2.0 tools for individually randomized, parallel group trials; cluster randomized, parallel group trials; and
individually randomized, cross-over trials (Higgins et al., 2016).
Disciplines
Research Methods in Life Sciences | Veterinary Medicine | Veterinary Preventive Medicine, Epidemiology,
and Public Health
Authors
C. B. Winder, K. J. Churchill, J. M. Sargeant, S. J. LeBlanc, A. M. O'Connor, and D. L. Renaud
This report is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/vdpam_reports/12
Study protocol: Reporting characteristics of intervention trials of  
animals published in the Journal of Dairy Science in 2017 
 
 
Protocol Version 2 
May 24, 2018 
 
Funding 
No outside source of funding was used for this study.  
 
Authors and affiliations 
Winder, C.B.1, K.J. Churchill1, J.M. Sargeant1,2,S.J. LeBlanc1, A.M. O’Connor3, D.L. Renaud1 
1 Dept. of Population Medicine, University of Guelph, Ontario, Canada, N1G 2W1 
2 Centre for Public Health and Zoonoses, University of Guelph, Ontario, Canada, N1G 2W1 
3 Dept. of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, 50011-
1134 
 
Expected contributions 
KC – screened studies, extracted data 
SL – developed proposal, reviewed manuscript 
AOC – developed proposal, reviewed manuscript 
DR – developed proposal, extracted data, analysed data, prepared manuscript 
JS – developed proposal, extracted data, reviewed manuscript 
CW – developed proposal, screened studies, extracted data, analysed data, prepared manuscript 
 
Objectives 
The scope of this cross-sectional observational study is to evaluate prevalence of reporting the 
19 objective items of the REFLECT statement checklist (Sargeant et al., 2010), with the primary 
outcome being prevalence of sample size calculation, in clinical trials published in the Journal of 
Dairy Science from January to December of 2017.  We will also determine risk of bias in 
individual studies using the Cochrane Risk of Bias 2.0 tools for individually randomized, parallel 
group trials; cluster randomized, parallel group trials; and individually randomized, cross-over 
trials (Higgins et al., 2016). 
 
Sample size 
Previous work examining reporting characteristics of studies evaluating the comparative efficacy 
of FDA-registered antimicrobials against naturally acquired BRD (bovine respiratory disease) in 
weaned beef calves in Canada or the USA found that 36 % of studies published after 2010 
reported a sample size calculation (Totten et al., 2018).  With an estimated a prevalence of 40 %, 
95 % confidence and a 6 % margin of error, we determined a sample size for our study of 219.  
We conservatively estimated our search terms would require exclusion of 2/3 of papers found, 
and therefore based our inclusion on a one-year period (2017), whose pilot search resulted in 
704 publications, which should yield approximately 230 inclusions.   
 
Study selection and screening 
The literature search will be conducted in MEDLINE via OVID (University of Guelph license) with 
the following string: (AB=(experiment OR study OR studies OR trial OR challenge) AND 
JN=(Journal of Dairy Science) AND limit to YR=“2017”).  Search results will be exported into 
DistillerSR (Ottawa, Ontario, Canada). All title/abstracts will be independently screened by KC 
and CW for relevance using the following criteria: 
 
1.) Does the title/abstract describe a primary study involving animals or groups of animals as 
the experimental unit?  (N, reject; Y, proceed;  Unclear, acquire full text and give Y/N) 
 
2.) Does the title/abstract describe an intervention study with at least one comparator 
group? (N, reject; Y, include; Unclear, acquire full text and give Y/N) 
 
Studies will be included/excluded using agreement at the form level.  Conflicts will be resolved 
by consensus with mediation by JS if needed.   
 
Data extraction 
Data will be extracted in DistillerSR (Ottawa, Ontario, Canada) independently in duplicate.  
Descriptive information extracted will include: location of the study (country), last author 
affiliation (department (if applicable) and institution), last author affiliation (country), animal 
specie(s), location setting (commercial, university/research, not reported), type of study (field 
trial or challenge study), and study design (parallel group or cross-over).  Field trials are defined 
as those completed in a clinical or field setting (including research herds) which involve 
investigator control of study unit selection and intervention allocation, but not exposure to 
disease, whereas challenge studies involve purposive disease exposure. Data from multiple 
studies presented in a single paper will be extracted separately but in a single form.   
 
Reporting characteristics. Reporting characteristics will be assessed using a comprehensive 
reporting assessment tool, based on the first 19 items of the REFLECT Statement, developed by 
Totten et al. (2018) and outlined in Table 1.  Some questions were slightly modified to remove 
specific outcomes of interest based on the objectives of their work. An additional question 
pertaining to cross-over studies was added. Reporting characteristics will be extracted by two of 
KC, DR, JS, or CW.  Conflicts at the question level will be resolved by consensus with mediation by 
JS or SL if needed. 
 
Risk of bias. Risk of bias will be assessed independently in duplicate by DR and CW using the 
Cochrane risk of bias 2.0 tools for individually randomized, parallel group trials, cluster 
randomized, parallel group trials, and individually randomized, cross-over trials (Higgins et al., 
2016).  Questions pertaining to blinding of ‘participants’ (animals/animal groups) were removed 
as was question 1b (for cluster randomized parallel group trials).  All other questions were 
included as outlined in Table 2.   Risk of bias will be assessed by two of KC, DR, JS, or CW with 
conflicts resolved by consensus with mediation by JS or SL if needed. 
 
 
Presentation of results 
A summary of descriptive information will be used to qualitatively present the breadth of work 
captured by the study selection and screening.  Prevalence of reporting characteristics will be 
presented in a table summarizing each question. Risk of bias will be presented as prevalence of 
category of risk of bias judgement for each bias domain. 
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Table 1.  Data extraction items for reporting characteristics in primary intervention studies 
published in the Journal of Dairy Science in 2017.  Questions were developed by Totten et al. 
(2018), although modifications were made to remove specifically referenced outcomes used in 
their study. One additional question pertaining to washout periods in cross-over studies was 
added (italics). 
 
REFLECT Statement 
checklist item 
 
1 In the Title and/or Abstract, did the investigators report that the study units were 
randomly allocated to the interventions?  
2 In the Introduction, did the investigators provide a scientific background of the topic 
and a rationale (explanation) for the study? 
3.1 In the Methods, did the investigators report eligibility criteria for the 
farm/owner/manager? 
3.2 In the Methods, did the investigators report study unit (animal or animal group) 
eligibility?  
3.3 In the Methods, was the setting where the data were collected described?  
4 In the Methods, did the investigators give precise details of the interventions intended 
for each group, the level at which the intervention was allocated, and how and when 
interventions were actually administered? 
5.1 Did the investigators report the specific objectives of the study? 
5.2 Did the investigators report the specific hypotheses of the study? 
6 Did the investigators give clearly defined primary and secondary outcome measures 
and the levels at which they were measured, and, when applicable, any methods used 
to enhance the quality of the measurements?  
7 Did the investigators report how the sample size was determined and, when 
applicable, give an explanation of any interim analyses and stopping rules? 
N/A Was there a washout period(s), and was there a rationale behind the period(s) 
explained? 
8 Did the investigators report the method used to generate the random allocation 
sequence at the relevant level of the organizational structure, including details of any 
restrictions? 
9 Did the investigators report the method used to implement the random allocation 
sequence at the relevant level of the organizational structure, (e.g. numbered 
containers), clarifying whether the sequence was concealed until interventions were 
assigned? 
10.1 Did the investigators report who generated the allocation sequence?  
10.2 Did the investigators report who enrolled study units? 
10.3 Did the investigators report who assigned study units to their groups at the relevant 
level of the organizational structure? 
11.1 Did the investigators report whether or not those administering the interventions were 
blinded?  
11.2 Did the investigators report whether or not caregivers were blinded?  
11.3 Did the investigators report whether or not those assessing the outcomes were 
blinded?  
11.4 Did the investigators report whether or not those analyzing the data were blinded? 
11.5 Did the investigators report blinding (or the absence of blinding) at all?  
12 Were statistical methods used to compare groups for all outcome(s), and did the 
investigators clearly state the level of statistical analysis and methods used to account 
for the organizational structure (where applicable)? 
13 In the Results, did the investigators report the flow of study units through each stage 
for each level of the organization structure of the study?  
14 Did the investigators report dates defining the periods of recruitment and follow-up? 
15 Did the investigators report the baseline demographic and clinical characteristics of 
each group, explicitly providing information for each relevant level of the 
organizational structure?  
16 Did the investigators report the number of study units (denominator) in each group 
included in each analysis and the results in absolute numbers when feasible? 
17 Did the investigators report a summary of results for each intervention group, 
accounting for each relevant level of the organizational structure, and the estimated 
effect size and its precision (e.g., 95% confidence interval)? 
18 Did the investigators address multiplicity by reporting any other analyses performed, 
including subgroup analyses and adjusted analyses, indicating those pre-specified and 
those exploratory?  
19 Did the investigators report all important adverse events or side effects in each 
intervention group?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Items from the Cochrane Risk of Bias 2.0 tool (Higgins et al., 2016) used to assess bias in 
included studies from the Journal of Dairy Science in 2017. 
 
 
 
Individually randomized, 
parallel group trials 
Cluster randomized, 
parallel group trials 
Individually randomized, 
cross-over trials 
Bias arising from the 
randomization process 
 
1.1, 1.2, 1.3 1a.1, 1a.2, 1a.3 1.1, 1.2, 1.3, 1.4, 1.5 
Bias due to deviations 
from intended 
interventions 
 
2.2, 2.3, 2.4, 2.5, 2.6 2.2, 2.3, 2.4, 2.5a, 2.5b, 2.6  2.2, 2.3, 2.4, 2.5, 2.6, 2.7 
Bias due to missing 
outcome data 
 
3.1, 3.2, 3.3 3.1a, 3.1b, 3.2, 3.3 3.1, 3.2, 3.3 
Bias in measurement of 
the outcome 
 
4.1, 4.2 4.1a, 4.1b, 4.2 4.1, 4.2 
Bias in selectin of the 
reported result 
5.1, 5.2 5.1, 5.2 5.1, 5.2, 5.3 
 
